Picture of Bavarian Nordic A/S logo

BAVA Bavarian Nordic A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Bavarian Nordic Says Awarded Contract Options From The U.S. Government For Production And Supply Of Freeze-Dried Smallpox Vaccines

May 11 (Reuters) - Bavarian Nordic A/S BAVA.CO:

BAVARIAN NORDIC AWARDED CONTRACT OPTIONS FROM THE U.S. GOVERNMENT FOR PRODUCTION AND SUPPLY OF FREEZE-DRIED SMALLPOX VACCINES

BAVARIAN NORDIC: UPGRADES FULL-YEAR FINANCIAL GUIDANCE

BAVARIAN NORDIC - EXERCISED OPTIONS TOTAL USD 97 MILLION FOR BULK AND FREEZE-DRIED VACCINE SUPPLY

BAVARIAN NORDIC - FREEZE-DRIED JYNNEOS DOSES TO BE DELIVERED IN 2027 UNDER 11.5 MILLION DOSE ORDER

BAVARIAN NORDIC - SECURES PUBLIC PREPAREDNESS CONTRACTS IN 2026 OF APPROX DKK 2,000 MILLION

BAVARIAN NORDIC - FY2026 GUIDANCE: REVENUE DKK 5,500-5,700 MILLION

BAVARIAN NORDIC - RAISES FY2026 EBITDA MARGIN GUIDANCE TO APPROX 28%

Source text: ID:nGNE36VH87

Further company coverage: BAVA.CO

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Bavarian Nordic A/S

See all news